This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Loging, W. T. Articles by Reisman, D. Search for Related Content PubMed PubMed Citation Articles by Loging, W. T. Articles by Reisman, D.

Elevated Expression of Ribosomal Protein Genes L37, RPP-1, and S2 in the Presence of Mutant p53¹

Department of Biological Sciences, University of South Carolina, Columbia, South Carolina 29208

The wild-type p53 protein is a DNA-binding transcription factor that activates genes such as p21, MDM2, GADD45, and Bax that are required for the regulation of cell cycle progression or apoptosis in response to DNA damage. Mutant forms of p53, which are transforming oncogenes and are expressed at high levels in tumor cells, generally have a reduced binding affinity for the consensus DNA sequence. Interestingly, some p53 mutants that are no longer effective at binding to the consensus DNA sequence and transactivating promoters containing this target site have acquired the ability to transform cells in culture, in part through their ability to transactivate promoters of a number of genes that are not targets of the wild-type protein. Certain p53 mutants are therefore considered to be gain-of-function mutants and appear to be promoting proliferation or transforming cells through their ability to alter the expression of novel sets of genes. Our goal is to identify genes that have altered expression in the presence of a specific mutant p53 (Arg to Trp mutation at codon 248) protein. Through examining differential gene expression in cells devoid of p53 expression and in cells that express high levels of mutant p53 protein, we have identified three ribosomal protein genes that have elevated expression in response to mutant p53. Consistent with these findings, the overexpression of a number of ribosomal protein genes in human tumors and evidence for their contribution to oncogenic transformation have been reported previously, although the mechanism leading to this overexpression has remained elusive. We show results that indicate that expression of these specific ribosomal protein genes is increased in the presence of the R248W p53 mutant, which provides a mechanism for their overexpression in human tumors.

This article has been cited by other articles:

				M. Hu and R. A. Shivdasani Overlapping Gene Expression in Fetal Mouse Intestine Development and Human Colorectal Cancer Cancer Res., October 1, 2005; 65(19): 8715 - 8722. [Abstract] [Full Text] [PDF]

				V. J.N. Bykov, N. Issaeva, G. Selivanova, and K. G. Wiman Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database Carcinogenesis, December 1, 2002; 23(12): 2011 - 2018. [Abstract] [Full Text] [PDF]